Related references
Note: Only part of the references are listed.RoBoT: a robust Bayesian hypothesis testing method for basket trials
Tianjian Zhou et al.
BIOSTATISTICS (2021)
Statistical design considerations for trials that study multiple indications
Alexander M. Kaizer et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2021)
Hierarchical Bayesian clustering design of multiple biomarker subgroups (HCOMBS)
Daniel Kang et al.
STATISTICS IN MEDICINE (2021)
The National Lung Matrix Trial of personalized therapy in lung cancer
Gary Middleton et al.
NATURE (2020)
A Bayesian basket trial design using a calibrated Bayesian hierarchical model
Yiyi Chu et al.
CLINICAL TRIALS (2018)
BLAST: Bayesian latent subgroup design for basket trials accounting for patient heterogeneity
Yiyi Chu et al.
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS (2018)
Bayesian basket trial design with exchangeability monitoring
Brian P. Hobbs et al.
STATISTICS IN MEDICINE (2018)
Bayesian hierarchical modeling based on multisource exchangeability
Alexander M. Kaizer et al.
BIOSTATISTICS (2018)
Statistical controversies in clinical research: basket trials, umbrella trials, and other master protocols: a review and examples
L. A. Renfro et al.
ANNALS OF ONCOLOGY (2017)
Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both
Janet Woodcock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
BOP2: Bayesian optimal design for phase II clinical trials with simple and complex endpoints
Heng Zhou et al.
STATISTICS IN MEDICINE (2017)
Increasing the efficiency of oncology basket trials using a Bayesian approach
Rong Liu et al.
CONTEMPORARY CLINICAL TRIALS (2017)
Robust exchangeability designs for early phase clinical trials with multiple strata
Beat Neuenschwander et al.
PHARMACEUTICAL STATISTICS (2016)
Adaptive Design for a Confirmatory Basket Trial in Multiple Tumor Types Based on a Putative Predictive Biomarker
R. A. Beckman et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2016)
The Bayesian basket design for genomic variant-driven phase II trials
Richard Simon et al.
SEMINARS IN ONCOLOGY (2016)
Statistical Design and Considerations of a Phase 3 Basket Trial for Simultaneous Investigation of Multiple Tumor Types in One Study
Cong Chen et al.
STATISTICS IN BIOPHARMACEUTICAL RESEARCH (2016)
Basket Trials and the Evolution of Clinical Trial Design in an Era of Genomic Medicine
Amanda J. Redig et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
NCI-MATCH Launch Highlights New Trial Design in Precision-Medicine Era
Caroline McNeil
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
NCI-MATCH Launch Highlights New Trial Design in Precision-Medicine Era
Caroline McNeil
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Bayesian hierarchical modeling of patient subpopulations: Efficient designs of Phase II oncology clinical trials
Scott M. Berry et al.
CLINICAL TRIALS (2013)
Adaptive adjustment of the randomization ratio using historical control data
Brian P. Hobbs et al.
CLINICAL TRIALS (2013)
Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
Anirudh Prahallad et al.
NATURE (2012)
BRAF Mutations in Hairy-Cell Leukemia
Enrico Tiacci et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Keith T. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Hierarchical Bayesian approaches to phase II trials in diseases with multiple subtypes
PF Thall et al.
STATISTICS IN MEDICINE (2003)
Share Paper
